Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of Vonaprazan in H. pylori eradication
IRCT20221207056738N1Phase 3Completed
- Sponsor
- National University of Medical Sciences
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of vonoprazan in Helicobacter pylori infection, sponsored by National University of Medical Sciences. Started Dec 2022; status: completed.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on IRCT20221207056738N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221207056738N1.